Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 6.43 Billion |
| USD 13.49 Billion | |
| % | |
|
U.S. Healthcare Analytics market, By Type (Prescriptive Analytics, Predictive Analytics, Descriptive Analytics), Component (Services, Software, Hardware), Delivery Model (On-Demand, On-Premise), Application (Clinical Analytics, Population Health Analytics, Operational and Administrative Analytics, Financial Analytics), End User (Healthcare Payers, Healthcare Providers and ACOS, HIES, MCOS, AND TPAS) – Industry Trends and Forecast to 2030.
The increase in healthcare prices as a result of improve operational efficiencies, expanding range of services, the desire to cut costs, and treatment effectiveness are the major drivers that propelled the healthcare analytics market's demand. In addition, the increasing amount of sophisticated data generated by the transformation from paper to electronic health records, as well as its ability to improve physician practice, will fuel the healthcare analytics market demand. Due to an increase in the use of big data in healthcare organizations to address risks connected with numerous chronic diseases, the healthcare analytics market is predicted to grow. Furthermore, the growing use of telemedicine solutions by various enterprises to lower operational costs and improve service quality is propelling the healthcare analytics market expansion. All of this will help the U.S. healthcare analytics market to grow during the forecast period of 2023 to 2030.
Data Bridge Market Research analyses that the U.S. healthcare analytics market which was USD 6.43 billion in 2022, and is expected to reach USD 13.49 billion by 2030, and is expected to undergo a CAGR of 10.2% during the forecast period of 2023 to 2030. “Software” dominates the component segment of the U.S. healthcare analytics market owing to increase in demand for analytical solutions as a result of the increased workload in healthcare industry. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Prescriptive Analytics, Predictive Analytics, Descriptive Analytics), Component (Services, Software, Hardware), Delivery Model (On-Demand, On-Premise), Application (Clinical Analytics, Population Health Analytics, Operational and Administrative Analytics, Financial Analytics), End User (Healthcare Payers, Healthcare Providers and ACOS, HIES, MCOS, AND TPAS)
|
|
Countries Covered
|
U.S.
|
|
Market Players Covered
|
IBM (U.S.), Wipro Limited (India), Allscripts Healthcare, LLC (U.S.), Cerner Corporation (U.S.), Health Catalyst (U.S.), Inovalon (U.S.), McKesson Corporation (U.S.), MEDEANALYTICS, INC. (U.S.), Optum, Inc. (U.S.), Oracle (U.S.), SAS Institute Inc. (U.S.), ExlService Holdings, Inc. (U.S.), CitiusTech Inc. (U.S.), IQVIA (U.S.), and GENERAL ELECTRIC (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Healthcare analytics assist healthcare professionals in finding opportunities to enhance patient engagement, clinical outcomes, patient engagement and care delivery. Healthcare analytics solutions make use of the vast amounts of collected data for offering organizations with actionable insights.
Drivers
The surge in the cost of various medical procedures, along with the reduction in reimbursements for laboratory services, accelerate the demand for healthcare interoperability solutions across healthcare providers and healthcare payers. As the population in the U.S. continues to age, there is a growing demand for medical procedures, related to chronic diseases. This is expected to surge the healthcare analytics market.
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Healthcare analytics enables experts in the field to identify opportunities to improve care delivery, clinical outcomes, operations, and patient engagement. Healthcare data analytics integrates real time and historical data to forecast trends, increase medical care, expose actionable insights, and fuel long term growth.
Opportunity
Ongoing advancements in hemostatic products, including the development of innovative materials and improved delivery systems, enhance the effectiveness and safety of these devices. These advancements attract healthcare providers looking for better options.
The healthcare analytics market will grow as healthcare prices rise as a result of improve operational efficiencies, an expanding range of services, the desire to cut costs, and treatment effectiveness. In addition, the increasing amount of sophisticated data generated by the transformation from paper to electronic health records, as well as its ability to improve physician practice, will fuel the healthcare analytics market demand.
Moreover, technical developments, as well as an increase in investor interest in healthcare analytical tools, will drive the healthcare analytics market growth.
Restraint/Challenge
The high cost of analytics solutions and concerns regarding inaccurate and inconsistent data are expected to obstruct market growth. Moreover, reluctance to adopt healthcare analytics solutions in emerging countries and issues with data integration are projected to challenge the healthcare analytics market in the forecast period of 2023-2030.
This U.S. healthcare analytics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the U.S. healthcare analytics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
The U.S. Healthcare analytics market is segmented on the basis of type, component, delivery model, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Component
Delivery Model
Application
End User
Type
Healthcare Infrastructure growth Installed base and New Technology Penetration
The U.S. Healthcare analytics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for U.S. healthcare analytics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the U.S. healthcare analytics market. The data is available for historic period 2015-2020.
The U.S. Healthcare analytics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to U.S. healthcare analytics market.
Some of the major players operating in the U.S. healthcare analytics market are:
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. HEALTHCARE ANALYTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE U.S. HEALTHCARE ANALYTICS MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMAPANY MARKET SHARE ANALYSIS
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 STANDARDS OF MEASUREMENT
2.2.8 VENDOR SHARE ANALYSIS
2.2.9 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.10 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 U.S. HEALTHCARE ANALYTICS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHT
5.1 PORTERS FIVE FORCES
5.2 REGULATORY STANDARDS
5.3 TECHNOLOGICAL TRENDS
5.4 PATENT ANALYSIS
5.5 CASE STUDY
5.6 VALUE CHAIN ANALYSIS
5.7 COMPANY COMPARITIVE ANALYSIS
5.8 PRICING ANALYSIS
6 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 HARDWARE
6.3 SOFTWARE
6.4 SERVICES
6.4.1 SUPPORT SERVICES
6.4.2 BUSINESS ANALYTICS SERVICES
7 U.S. HEALTHCARE ANALYTICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 PRESCRIPTIVE ANALYTICS
7.3 PREDICTIVE ANALYTICS
7.4 DESCRIPTIVE ANALYTICS
7.5 COGNITIVE ANALYTICS
8 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL
8.1 OVERVIEW
8.2 ON-DEMAND
8.3 ON-PREMISES
9 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL ANALYTICS
9.2.1 REGULATORY REPORTING AND COMPLIANCE
9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING
9.2.3 CLINICAL DECISION SUPPORT
9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS
9.2.5 PRECISION HEALTH
9.3 POPULATION HEALTH ANALYTICS
9.3.1 POPULATION CARE MANAGEMENT
9.3.2 POPULATION RISK MANAGEMENT
9.3.3 CLINICAL OUTCOME MANAGEMENT
9.3.4 ACTIVITY-BASED COSTING
9.4 FINANCIAL ANALYTICS
9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA)
9.4.2 REVENUE CYCLE MANAGEMENT (RCM)
9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT
9.4.4 CLAIMS PROCESSING
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS
9.5.1 SUPPLY CHAIN ANALYTICS
9.5.2 WORKFORCE ANALYTICS
9.5.3 RESEARCH ANALYTICS
9.5.4 MARKET INTELLIGENCE
9.5.5 ENTERPRISE PERFORMANCE
9.5.6 STRATEGIC ANALYTICS
10 U.S. HEALTHCARE ANALYTICS MARKET, BY END USER
10.1 OVERVIEW
10.2 HEALTHCARE PAYERS
10.2.1 GOVERNMENT AGENCIES
10.2.2 PRIVATE INSURANCE COMPANIES
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
10.3 HEALTHCARE PROVIDERS
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
10.3.2 AMBULATORY SETTINGS
10.3.3 POST-ACUTE CARE ORGANIZATIONS
10.4 ACCOUNTABLE CARE ORGANIZATIONS (ACOS)
10.5 MANAGED CARE ORGANIZATION (MCOS)
10.6 TPAS (THIRD PARTY ADMINISTRATOR)
10.7 OTHERS
11 U.S. HEALTHCARE ANALYTICS MARKET,COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: U.S.
11.2 MERGERS & ACQUISITIONS
11.3 NEW PRODUCT DEVELOPMENT AND APPROVALS
11.4 EXPANSIONS
11.5 REGULATORY CHANGES
11.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 U.S. HEALTHCARE ANALYTICS MARKET, SWOT & DBMR ANALYSIS
13 U.S. HEALTHCARE ANALYTICS MARKET, COMPANY PROFILE
13.1 SISENSE LTD
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENT
13.2 INFOSYS LIMITED
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 ARCADIA SOLUTIONS, LLC. (A PART OF POHLAD COMPANIES)
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 ORACLE
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 SAS INSTITUTE INC
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 SNOWFLAKE INC
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 THOUGHTSPOT INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 ALTERYX
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 OPTUM, INC (A PART OF UNITEDHEALTH GROUP INC)
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 CITIUSTECH HEALTHCARE TECHNOLOGY PRIVATE LIMITED
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 WIPRO
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENT
13.12 EXLSERVICE HOLDINGS, INC
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 HEALTH CATALYST
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 IBM
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENT
13.15 SALESFORCE, INC.
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 CLARIFY HEALTH SOLUTIONS
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 QLIKTECH INTERNATIONAL AB,
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS
17 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.